Cargando…

Bufalin attenuates triple-negative breast cancer cell stemness by inhibiting the expression of SOX2/OCT4

Triple-negative breast cancer (TNBC) has the poorest prognosis among all types of breast cancer and there is yet no effective therapy. Chemotherapy is the traditional standard of care for patients with TNBC; however, treatment of TNBC with chemotherapy may lead to the enrichment of cancer stem cells...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chen, Fei, Zhu, Li, Hu, Junyan, Jiang, Shujun, Liu, Hui, Zheng, Jie, Wang, Jiandong, Wang, Feng, Li, Zhe
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	D.A. Spandidos 2020
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7471667/ https://www.ncbi.nlm.nih.gov/pubmed/32934738 http://dx.doi.org/10.3892/ol.2020.12028

Ejemplares similares

Steroid Receptor Coactivator-3 (SRC-3/AIB1) as a Novel Therapeutic Target in Triple Negative Breast Cancer and Its Inhibition with a Phospho-Bufalin Prodrug
por: Song, Xianzhou, et al.
Publicado: (2015)

Bufalin reverses acquired drug resistance by inhibiting stemness in colorectal cancer cells
por: Sun, Jian, et al.
Publicado: (2017)

Bufalin attenuates the stage and metastatic potential of hepatocellular carcinoma in nude mice
por: Zhang, Zhou-Ji, et al.
Publicado: (2014)

Expression of SOX10 in Triple-Negative Breast Carcinoma in Pakistan
por: Ali, Seemal, et al.
Publicado: (2022)

The Research Progress of Bufalin in the Treatment of Hepatocellular Carcinoma
por: Jiang, Han-yu, et al.
Publicado: (2022)

SOX2 Promotes Cell Proliferation and Metastasis in Triple Negative Breast Cancer
por: Liu, Peng, et al.
Publicado: (2018)

Clinicopathological significance of Sox10 expression in triple-negative breast carcinoma
por: Jin, Linfang, et al.
Publicado: (2020)

Negative reciprocity, not ordered assembly, underlies the interaction of Sox2 and Oct4 on DNA
por: Biddle, John W, et al.
Publicado: (2019)

Bufalin inhibits gastric cancer invasion and metastasis by down-regulating Wnt/ASCL2 expression
por: Wang, Jie, et al.
Publicado: (2018)

Elevating the levels of Sox2 in embryonal carcinoma cells and embryonic stem cells inhibits the expression of Sox2:Oct-3/4 target genes(†)
por: Boer, Brian, et al.
Publicado: (2007)

Immunoexpression of stem cell markers SOX-2, NANOG AND OCT4 in ameloblastoma
por: Martins Balbinot, Karolyny, et al.
Publicado: (2023)

Phosphorylation of Threonine(343) Is Crucial for OCT4 Interaction with SOX2 in the Maintenance of Mouse Embryonic Stem Cell Pluripotency
por: Abulaiti, Xianmixinuer, et al.
Publicado: (2017)

Immunoexpression of P63 and SOX2 in triple-negative breast cancers, Indonesia
por: Kamarlis, Reno K, et al.
Publicado: (2018)

Bufalin suppresses colorectal cancer cell growth through promoting autophagy in vivo and in vitro
por: Pan, Zhe, et al.
Publicado: (2018)

The dyskerin ribonucleoprotein complex as an OCT4/SOX2 coactivator in embryonic stem cells
por: Fong, Yick W, et al.
Publicado: (2014)

Enhanced Intestinal Permeability of Bufalin by a Novel Bufalin-Peptide-Dendrimer Inclusion through Caco-2 Cell Monolayer
por: Chan, Chi-on, et al.
Publicado: (2017)

A Novel Bufalin Derivative Exhibited Stronger Apoptosis-Inducing Effect than Bufalin in A549 Lung Cancer Cells and Lower Acute Toxicity in Mice
por: Liu, Miao, et al.
Publicado: (2016)

Deciphering the Sox-Oct partner code by quantitative cooperativity measurements
por: Ng, Calista K. L., et al.
Publicado: (2012)

Bufalin Inhibits Proliferation and Induces Apoptosis in Osteosarcoma Cells by Downregulating MicroRNA-221
por: Zhang, Jianjun, et al.
Publicado: (2016)

Bufalin suppresses tumour microenvironment-mediated angiogenesis by inhibiting the STAT3 signalling pathway
por: Fang, Kai, et al.
Publicado: (2021)

Immune Checkpoint Inhibition for Triple-Negative Breast Cancer: Current Landscape and Future Perspectives
por: Yi, Huimei, et al.
Publicado: (2021)

MK2206 enhances the cytocidal effects of bufalin in multiple myeloma by inhibiting the AKT/mTOR pathway
por: Xiang, Ru-Fang, et al.
Publicado: (2017)

Bufalin Induces Lung Cancer Cell Apoptosis via the Inhibition of PI3K/Akt Pathway
por: Zhu, Zhitu, et al.
Publicado: (2012)

Bufalin, a component in Chansu, inhibits proliferation and invasion of hepatocellular carcinoma cells
por: Qiu, Dong-Ze, et al.
Publicado: (2013)

Bufalin enhances antitumor effect of paclitaxel on cervical tumorigenesis via inhibiting the integrin α2/β5/FAK signaling pathway
por: Liu, Fei, et al.
Publicado: (2016)

Anti-Inflammatory and Antinociceptive Activities of Bufalin in Rodents
por: Wen, Lili, et al.
Publicado: (2014)

Synthesis and Biological Evaluation of Novel Bufalin Derivatives
por: Sampath, VishnuPriya, et al.
Publicado: (2022)

Bufalin suppresses cancer stem-like cells in gemcitabine-resistant pancreatic cancer cells via Hedgehog signaling
por: Wang, Haiyong, et al.
Publicado: (2016)

Bufalin reverses ABCB1-mediated resistance to docetaxel in breast cancer
por: Zhang, Die, et al.
Publicado: (2023)

Differential Nucleosome Occupancies across Oct4-Sox2 Binding Sites in Murine Embryonic Stem Cells
por: Sebeson, Amy, et al.
Publicado: (2015)

Lovastatin Inhibits EMT and Metastasis of Triple-Negative Breast Cancer Stem Cells Through Dysregulation of Cytoskeleton-Associated Proteins
por: Zheng, Chanjuan, et al.
Publicado: (2021)

lncRNA LUCAT1/ELAVL1/LIN28B/SOX2 Positive Feedback Loop Promotes Cell Stemness in Triple-Negative Breast Cancer
por: Xia, Li, et al.
Publicado: (2022)

Inhibition of miR-214 attenuates the migration and invasion of triple-negative breast cancer cells
por: Zhang, Yi, et al.
Publicado: (2019)

Transcriptional Regulation of Vih by Oct4 and Sox9 in Scylla paramamosain
por: Liao, Jiaqian, et al.
Publicado: (2020)

Bufalin Induces Apoptosis and Improves the Sensitivity of Human Glioma Stem-Like Cells to Temozolamide
por: Liu, Jia, et al.
Publicado: (2019)

Interplay of Oct4 with Sox2 and Sox17: a molecular switch from stem cell pluripotency to specifying a cardiac fate
por: Stefanovic, Sonia, et al.
Publicado: (2009)

Targeted Therapeutic Strategies for Triple-Negative Breast Cancer
por: Li, Ying, et al.
Publicado: (2021)

Improved Antitumor Efficacy and Pharmacokinetics of Bufalin via PEGylated Liposomes
por: Yuan, Jiani, et al.
Publicado: (2017)

Inhibition of Jak-STAT3 pathway enhances bufalin-induced apoptosis in colon cancer SW620 cells
por: Zhu, Zhitu, et al.
Publicado: (2012)

Expression of SOX2 and OCT4 in odontogenic cysts and tumors
por: Phattarataratip, Ekarat, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_bd0po7e5fi4nst74rqhtcfeuhn